Cargando…

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020

BACKGROUND: The impact of clinical and sociodemographic factors on fatigue remains unknown among patients with substance use disorders (SUD). This study aims to evaluate fatigue among patients with SUD using a nine-item fatigue severity scale (FSS-9) and identify the impact that clinical and sociode...

Descripción completa

Detalles Bibliográficos
Autores principales: Vold, Jørn Henrik, Gjestad, Rolf, Aas, Christer F., Chalabianloo, Fatemeh, Skurtveit, Svetlana, Løberg, Else-Marie, Johansson, Kjell Arne, Fadnes, Lars Thore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737389/
https://www.ncbi.nlm.nih.gov/pubmed/33317568
http://dx.doi.org/10.1186/s13011-020-00334-x
_version_ 1783622932265697280
author Vold, Jørn Henrik
Gjestad, Rolf
Aas, Christer F.
Chalabianloo, Fatemeh
Skurtveit, Svetlana
Løberg, Else-Marie
Johansson, Kjell Arne
Fadnes, Lars Thore
author_facet Vold, Jørn Henrik
Gjestad, Rolf
Aas, Christer F.
Chalabianloo, Fatemeh
Skurtveit, Svetlana
Løberg, Else-Marie
Johansson, Kjell Arne
Fadnes, Lars Thore
author_sort Vold, Jørn Henrik
collection PubMed
description BACKGROUND: The impact of clinical and sociodemographic factors on fatigue remains unknown among patients with substance use disorders (SUD). This study aims to evaluate fatigue among patients with SUD using a nine-item fatigue severity scale (FSS-9) and identify the impact that clinical and sociodemographic factors – such as injecting substance use, chronic infectious diseases, liver fibrosis, opioid agonist therapy (OAT), debt difficulties, and housing situation – have on fatigue. METHODS: We used data from a cohort of patients with SUD in Norway with annual health assessments surveying FSS-9 and some clinical and sociodemographic factors. A total of 915 FSS-9 measurements were collected from 654 patients during the period 2016–2020. We defined baseline as the first annual health assessment when the health assessments were listed chronologically. Time was defined as years from baseline. We used a linear mixed model to analyse whether the clinical and sociodemographic factors affected the FSS-9 sum score, presented with beta coefficients (β) with 95% confidence intervals (CI). RESULTS: The mean sum score of the FSS-9 was 43 (standard deviation: 16) at baseline. Females compared with males (adjusted mean difference of FSS-9 sum score: 4.1, 95% CI: 1.3–7.0), having debt difficulties compared with having no debt difficulties (2.9;0.4–5.3), and frequent use of benzodiazepines (5.7;3.0–8.4) or amphetamines (-5.0;-8.0– -2.0) compared to less frequent or no use of these substances changed the FSS-9 baseline sum score. The other clinical and sociodemographic factors did not predict any clinically relevant change in the FSS-9 sum score from baseline to the following health assessments. CONCLUSION: Patients with SUD suffer from high levels of fatigue. Female patients, patients with debt difficulties, and those with extensive use of benzodiazepines are at particular risk of being fatigued. This should be taken into consideration when planning health services. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13011-020-00334-x.
format Online
Article
Text
id pubmed-7737389
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77373892020-12-17 Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020 Vold, Jørn Henrik Gjestad, Rolf Aas, Christer F. Chalabianloo, Fatemeh Skurtveit, Svetlana Løberg, Else-Marie Johansson, Kjell Arne Fadnes, Lars Thore Subst Abuse Treat Prev Policy Research BACKGROUND: The impact of clinical and sociodemographic factors on fatigue remains unknown among patients with substance use disorders (SUD). This study aims to evaluate fatigue among patients with SUD using a nine-item fatigue severity scale (FSS-9) and identify the impact that clinical and sociodemographic factors – such as injecting substance use, chronic infectious diseases, liver fibrosis, opioid agonist therapy (OAT), debt difficulties, and housing situation – have on fatigue. METHODS: We used data from a cohort of patients with SUD in Norway with annual health assessments surveying FSS-9 and some clinical and sociodemographic factors. A total of 915 FSS-9 measurements were collected from 654 patients during the period 2016–2020. We defined baseline as the first annual health assessment when the health assessments were listed chronologically. Time was defined as years from baseline. We used a linear mixed model to analyse whether the clinical and sociodemographic factors affected the FSS-9 sum score, presented with beta coefficients (β) with 95% confidence intervals (CI). RESULTS: The mean sum score of the FSS-9 was 43 (standard deviation: 16) at baseline. Females compared with males (adjusted mean difference of FSS-9 sum score: 4.1, 95% CI: 1.3–7.0), having debt difficulties compared with having no debt difficulties (2.9;0.4–5.3), and frequent use of benzodiazepines (5.7;3.0–8.4) or amphetamines (-5.0;-8.0– -2.0) compared to less frequent or no use of these substances changed the FSS-9 baseline sum score. The other clinical and sociodemographic factors did not predict any clinically relevant change in the FSS-9 sum score from baseline to the following health assessments. CONCLUSION: Patients with SUD suffer from high levels of fatigue. Female patients, patients with debt difficulties, and those with extensive use of benzodiazepines are at particular risk of being fatigued. This should be taken into consideration when planning health services. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13011-020-00334-x. BioMed Central 2020-12-14 /pmc/articles/PMC7737389/ /pubmed/33317568 http://dx.doi.org/10.1186/s13011-020-00334-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Vold, Jørn Henrik
Gjestad, Rolf
Aas, Christer F.
Chalabianloo, Fatemeh
Skurtveit, Svetlana
Løberg, Else-Marie
Johansson, Kjell Arne
Fadnes, Lars Thore
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
title Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
title_full Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
title_fullStr Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
title_full_unstemmed Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
title_short Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
title_sort impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from norway for the period 2016–2020
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737389/
https://www.ncbi.nlm.nih.gov/pubmed/33317568
http://dx.doi.org/10.1186/s13011-020-00334-x
work_keys_str_mv AT voldjørnhenrik impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020
AT gjestadrolf impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020
AT aaschristerf impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020
AT chalabianloofatemeh impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020
AT skurtveitsvetlana impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020
AT løbergelsemarie impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020
AT johanssonkjellarne impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020
AT fadneslarsthore impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020
AT impactofclinicalandsociodemographicfactorsonfatigueamongpatientswithsubstanceusedisorderacohortstudyfromnorwayfortheperiod20162020